IBDEI2VO ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45909,1,4,0)
 ;;=4^H34.11
 ;;^UTILITY(U,$J,358.3,45909,2)
 ;;=^5005557
 ;;^UTILITY(U,$J,358.3,45910,0)
 ;;=H34.12^^176^2293^10
 ;;^UTILITY(U,$J,358.3,45910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45910,1,3,0)
 ;;=3^Central Retinal Artery Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,45910,1,4,0)
 ;;=4^H34.12
 ;;^UTILITY(U,$J,358.3,45910,2)
 ;;=^5005558
 ;;^UTILITY(U,$J,358.3,45911,0)
 ;;=H34.231^^176^2293^1
 ;;^UTILITY(U,$J,358.3,45911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45911,1,3,0)
 ;;=3^Branch Retinal Artery Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,45911,1,4,0)
 ;;=4^H34.231
 ;;^UTILITY(U,$J,358.3,45911,2)
 ;;=^5005564
 ;;^UTILITY(U,$J,358.3,45912,0)
 ;;=H34.232^^176^2293^2
 ;;^UTILITY(U,$J,358.3,45912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45912,1,3,0)
 ;;=3^Branch Retinal Artery Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,45912,1,4,0)
 ;;=4^H34.232
 ;;^UTILITY(U,$J,358.3,45912,2)
 ;;=^5005565
 ;;^UTILITY(U,$J,358.3,45913,0)
 ;;=H35.031^^176^2293^17
 ;;^UTILITY(U,$J,358.3,45913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45913,1,3,0)
 ;;=3^Hypertensive Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,45913,1,4,0)
 ;;=4^H35.031
 ;;^UTILITY(U,$J,358.3,45913,2)
 ;;=^5005590
 ;;^UTILITY(U,$J,358.3,45914,0)
 ;;=H35.032^^176^2293^18
 ;;^UTILITY(U,$J,358.3,45914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45914,1,3,0)
 ;;=3^Hypertensive Retinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,45914,1,4,0)
 ;;=4^H35.032
 ;;^UTILITY(U,$J,358.3,45914,2)
 ;;=^5005591
 ;;^UTILITY(U,$J,358.3,45915,0)
 ;;=H35.033^^176^2293^19
 ;;^UTILITY(U,$J,358.3,45915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45915,1,3,0)
 ;;=3^Hypertensive Retinopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,45915,1,4,0)
 ;;=4^H35.033
 ;;^UTILITY(U,$J,358.3,45915,2)
 ;;=^5005592
 ;;^UTILITY(U,$J,358.3,45916,0)
 ;;=H35.82^^176^2293^23
 ;;^UTILITY(U,$J,358.3,45916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45916,1,3,0)
 ;;=3^Retinal Ischemia/Cotton Wool Spot
 ;;^UTILITY(U,$J,358.3,45916,1,4,0)
 ;;=4^H35.82
 ;;^UTILITY(U,$J,358.3,45916,2)
 ;;=^5005716
 ;;^UTILITY(U,$J,358.3,45917,0)
 ;;=H35.61^^176^2293^21
 ;;^UTILITY(U,$J,358.3,45917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45917,1,3,0)
 ;;=3^Retinal Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,45917,1,4,0)
 ;;=4^H35.61
 ;;^UTILITY(U,$J,358.3,45917,2)
 ;;=^5005699
 ;;^UTILITY(U,$J,358.3,45918,0)
 ;;=H35.62^^176^2293^22
 ;;^UTILITY(U,$J,358.3,45918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45918,1,3,0)
 ;;=3^Retinal Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,45918,1,4,0)
 ;;=4^H35.62
 ;;^UTILITY(U,$J,358.3,45918,2)
 ;;=^5005700
 ;;^UTILITY(U,$J,358.3,45919,0)
 ;;=H35.051^^176^2293^24
 ;;^UTILITY(U,$J,358.3,45919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45919,1,3,0)
 ;;=3^Retinal Neovascularization,Right Eye
 ;;^UTILITY(U,$J,358.3,45919,1,4,0)
 ;;=4^H35.051
 ;;^UTILITY(U,$J,358.3,45919,2)
 ;;=^5005598
 ;;^UTILITY(U,$J,358.3,45920,0)
 ;;=H35.052^^176^2293^25
 ;;^UTILITY(U,$J,358.3,45920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45920,1,3,0)
 ;;=3^Retinal Neovascularization,Left Eye
 ;;^UTILITY(U,$J,358.3,45920,1,4,0)
 ;;=4^H35.052
 ;;^UTILITY(U,$J,358.3,45920,2)
 ;;=^5005599
 ;;^UTILITY(U,$J,358.3,45921,0)
 ;;=H35.071^^176^2293^26
 ;;^UTILITY(U,$J,358.3,45921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45921,1,3,0)
 ;;=3^Retinal Telangiectasis,Right Eye
 ;;^UTILITY(U,$J,358.3,45921,1,4,0)
 ;;=4^H35.071
